These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1631250)

  • 1. Level of haloperidol in plasma is related to electroencephalographic findings in patients who improve.
    Czobor P; Volavka J
    Psychiatry Res; 1992 May; 42(2):129-44. PubMed ID: 1631250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
    Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ
    Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment EEG predicts short-term response to haloperidol treatment.
    Czobor P; Volavka J
    Biol Psychiatry; 1991 Nov; 30(9):927-42. PubMed ID: 1747438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of determination of plasma haloperidol levels.
    Santos JL; Cabranes JA; Almoguera I; Ramos JA; Vazquez C; Angeles F
    Acta Psychiatr Scand; 1989 Apr; 79(4):348-54. PubMed ID: 2735205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slower theta activity over the midfrontal cortex in schizophrenic patients.
    Westphal KP; Grözinger B; Diekmann V; Scherb W; Reess J; Leibing U; Kornhuber HH
    Acta Psychiatr Scand; 1990 Feb; 81(2):132-8. PubMed ID: 2327275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients.
    Chang WH; Lin SK; Jann MW; Lam YW; Chen TY; Chen CT; Hu WH; Yeh EK
    Biol Psychiatry; 1989 Jul; 26(3):239-49. PubMed ID: 2742942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEEG mapping in drug-free schizophrenics. Differences from healthy subjects and changes induced by haloperidol treatment.
    Galderisi S; Mucci A; Mignone ML; Maj M; Kemali D
    Schizophr Res; 1991 Dec; 6(1):15-23. PubMed ID: 1786232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
    Czobor P; Volavka J
    J Clin Psychopharmacol; 1993 Oct; 13(5):332-42. PubMed ID: 7693770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative symptoms and EEG alpha activity in schizophrenic patients.
    Merrin EL; Floyd TC
    Schizophr Res; 1992 Oct; 8(1):11-20. PubMed ID: 1358182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state study.
    Chang WH; Lin SK; Jann MW
    J Clin Psychopharmacol; 1991 Apr; 11(2):99-105. PubMed ID: 2056148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of rapid neuroleptic response in male patients with schizophrenia.
    Petrie EC; Faustman WO; Moses JA; Lombrozo L; Csernansky JG
    Psychiatry Res; 1990 Aug; 33(2):171-7. PubMed ID: 2243894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative EEG and BPRS data following Haldol-Decanoate administration in schizophrenics.
    Schellenberg R; Milch W; Schwarz A; Schober F; Dimpfel W
    Int Clin Psychopharmacol; 1994; 9(1):17-24. PubMed ID: 7910833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
    Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
    Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clozapine increases EEG photic driving in clinical responders.
    Jin Y; Potkin SG; Sandman C
    Schizophr Bull; 1995; 21(2):263-8. PubMed ID: 7631173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Average reference EEG lateralization in schizophrenic patients.
    Merrin EL; Floyd TC
    J Neuropsychiatry Clin Neurosci; 1991; 3(3):307-14. PubMed ID: 1687964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EEG hemispheric asymmetry as a predictor and correlate of short-term response to clozapine treatment in schizophrenia.
    Knott V; Labelle A; Jones B; Mahoney C
    Clin Electroencephalogr; 2000 Jul; 31(3):145-52. PubMed ID: 10923202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total and free plasma neuroleptic levels in schizophrenic patients.
    Tang SW; Glaister J; Davidson L; Toth R; Jeffries JJ; Seeman P
    Psychiatry Res; 1984 Dec; 13(4):285-93. PubMed ID: 6596586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-EEG brain mapping in DSM-III schizophrenics after acute and chronic haloperidol treatment.
    Galderisi S; Mucci A; Di Gregorio MR; Bucci P; Maj M; Kemali D
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):51-4. PubMed ID: 2136214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/haloperidol.
    Saletu B; Küfferle B; Anderer P; Grünberger J; Steinberger K
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):27-36. PubMed ID: 1983779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.